Contrast the pathophysiology of type 1 and type 2 diabetes.

Study for the Health CBE Exam. Prepare with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

The main idea here is how insulin production and action differ between the two types. In type 1, an autoimmune process destroys the pancreatic beta cells that make insulin, leading to an almost complete lack of insulin production—an absolute insulin deficiency. This is why individuals with type 1 often have low or undetectable C-peptide and may have autoantibodies against beta-cell components; they typically require lifelong insulin therapy. In type 2, the problem starts with insulin resistance in peripheral tissues, so the body's cells don’t use insulin effectively. The pancreas initially compensates by producing more insulin, but over time beta cells can fail, leaving a relative deficiency rather than an absolute one. This pattern fits with associations to obesity and metabolic syndrome, and treatment often begins with lifestyle changes and oral medications, with insulin added later if needed. The statement is best because it accurately distinguishes autoimmune beta-cell destruction with absolute insulin deficiency from insulin resistance with a relative deficiency. The other descriptions mix up the mechanisms, rely on age alone, or oversimplify management, which doesn’t reflect the fundamental pathophysiology.